4//SEC Filing
Amoroso Michael 4
Accession 0001628280-25-048855
CIK 0001357874other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 4:15 PM ET
Size
9.1 KB
Accession
0001628280-25-048855
Insider Transaction Report
Form 4
Amoroso Michael
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-11-02+9,444→ 118,984 total - Sale
Common Stock
2025-11-03$6.49/sh−3,409$22,124→ 115,575 total - Exercise/Conversion
Restricted Stock Units
2025-11-03−9,444→ 0 total→ Common Stock (9,444 underlying)
Footnotes (4)
- [F1]Represents the vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2025.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]The sales were effected pursuant to a Rule 10b5-1 plan adopted on August 2, 2024. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- [F4]On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on November 2, 2025.
Documents
Issuer
PRECISION BIOSCIENCES INC
CIK 0001357874
Entity typeother
Related Parties
1- filerCIK 0001830874
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 4:15 PM ET
- Size
- 9.1 KB